CANCER 52
To promote and protect the health and sufferers of rare and less common cancers for the public benefit by :(a) Promoting understanding, awareness and research about rare and less common cancers(b) acting as a collective voice and advocating needs of individuals affected by a rare or less common cancers(c)supporting not-for-profit organisations in field of rare and less common cancers
Objects
TO PROMOTE AND PROTECT THE HEALTH OF SUFFERERS OF RARE AND LESS COMMON CANCERS FOR THE PUBLIC BENEFIT BY:(A) ADVANCING AND PROMOTING THE UNDERSTANDING, AWARENESS, RESEARCH AND LEARNING ABOUT RARE AND LESS COMMON CANCERS;(B) ACTING AS A COLLECTIVE VOICE AND ADVOCATING FOR THE NEEDS OF INDIVIDUALS AFFECTED BY A RARE OR LESS COMMON CANCER IN ORDER TO IMPROVE THE OUTCOMES OF DIAGNOSIS, TREATMENT AND LONG-TERM SUPPORT; AND(C) SUPPORTING, REPRESENTING AND EMPOWERING NOT-FOR-PROFIT ORGANISATIONS WORKING IN THE FIELD OF RARE AND LESS COMMON CANCER.
Financial health, per its FY2025 accounts
The accounts state that Cancer52 generated a surplus of £14,819 for the year ended 31 March 2025, with total income of £363,420 against expenditure of £348,601. Per the trustees' report, unrestricted reserves increased to £65,732, which the Board considers sufficient to cover five months of operational running costs in line with their stated policy of holding between five and seven months' expenditure.
What the accounts disclose
“This means that we aim to hold between five and seven months’ unrestricted annual expenditure in reserve.”
Policies the charity declares
- Bullying and harassment policy and procedures
- Campaigns and political activity policy and procedures
- Complaints handling
- Complaints policy and procedures
- Conflicting interests
- Engaging external speakers at charity events policy and procedures
- Financial reserves policy and procedures
- Internal charity financial controls policy and procedures
- Internal risk management policy and procedures
- Investing charity funds policy and procedures
- Investment
- Risk management
- Safeguarding policy and procedures
- Serious incident reporting policy and procedures
- Social media policy and procedures
- Trustee conflicts of interest policy and procedures
- Trustee expenses policy and procedures
Funders the charity credits
- The National Lottery Community Fund
- AstraZeneca
Trustees
- Anne MacDowellchair
- Amanda Boughey
- Anna Evans
- Clare Clifton
- Dr Max Brodermann
- Michael Draeger
- Nic Puntis
- Sophie Davies
- Willemke Dagmar Droogsma
- Yasmin Sheikh
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 31/03/2025 | £363k | £349k |
| 31/03/2024 | £231k | £269k |
| 31/03/2023 | £177k | £198k |
| 31/03/2022 | £145k | £151k |
| 31/03/2021 | £176k | £126k |
Common questions
Is CANCER 52 financially healthy?
Per its FY2025 accounts: The accounts state that Cancer52 generated a surplus of £14,819 for the year ended 31 March 2025, with total income of £363,420 against expenditure of £348,601. Per the trustees' report, unrestricted reserves increased to £65,732, which the Board considers sufficient to cover five months of operational running costs in line with their stated policy of holding between five and seven months' expenditure. Its FY2025 accounts were independently examined.
Government & lottery funding
| Funder | Date | Amount | Purpose |
|---|---|---|---|
| The National Lottery Community Fund | 31/08/2023 | £466k | Supporting Cancer52's organisational development and growth |
Funders of similar charities
| Funder | Similar charities funded | Amount to them |
|---|---|---|
| THE PHILIP J MILTON AND COMPANY PLC CHARITABLE FOUNDATION | 1 | — |
| THE CHARLES WOLFSON CHARITABLE TRUST | 1 | £287k |
| ACHISOMOCH AID COMPANY LIMITED | 1 | £284k |
| JNF CHARITABLE TRUST | 1 | £222k |
| THE RICHARD HARRIS CHARITABLE TRUST | 1 | £115k |
| NORTH WEST CANCER RESEARCH (INCORPORATING CLATTERBRIDGE CANCER RESEARCH CCR) | 1 | £101k |
| THE RUBIN FOUNDATION CHARITABLE TRUST | 1 | £100k |
| WALTERS FAMILY CHARITABLE FOUNDATION | 1 | £86k |
Charities like this
- CANCER RESEARCH WALES
- EHE RARE CANCER CHARITY (UK)
- SARCOMA UK
- THE CHILDREN'S CANCER AND LEUKAEMIA GROUP
- CANCER AWARENESS TRUST
- THE CANCER TREATMENT AND RESEARCH TRUST CIO
Side by side with its peers
| Charity | Income | Top pay band | Staff >£60k | Reserves vs policy | Fundraising cost | Going concern |
|---|---|---|---|---|---|---|
| CANCER 52 | £363k | — | 0 | within | — | no doubt |
| CANCER RESEARCH WALES | £5.9m | — | — | unclear | — | no doubt |
| EHE RARE CANCER CHARITY (UK) | £133k | — | 0 | unclear | — | no doubt |
| SARCOMA UK | £4.6m | — | — | above | 26.0% | no doubt |
| THE CHILDREN'S CANCER AND LEUKAEMIA GROUP | £5.5m | — | — | below | — | no doubt |
| CANCER AWARENESS TRUST | £1.1m | £100,001 - £110,000 | — | unclear | — | no doubt |